Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 225

1.

Isolated myeloperoxidase expression in pediatric B/myeloid mixed phenotype acute leukemia is linked with better survival.

Raikar SS, Park SI, Leong T, Jaye DL, Keller FG, Horan JT, Woods WG.

Blood. 2018 Feb 1;131(5):573-577. doi: 10.1182/blood-2017-09-807602. Epub 2017 Dec 9. No abstract available.

PMID:
29223952
2.

Central nervous system disease in pediatric acute myeloid leukemia: A report from the Children's Oncology Group.

Johnston DL, Alonzo TA, Gerbing RB, Aplenc R, Woods WG, Meshinchi S, Gamis AS.

Pediatr Blood Cancer. 2017 Dec;64(12). doi: 10.1002/pbc.26612. Epub 2017 Apr 28.

3.

Health-related Quality of Life (HR-QOL) and Chronic Health Conditions in Survivors of Childhood Acute Myeloid Leukemia (AML) with Down Syndrome (DS): A Report From the Children's Oncology Group.

Schultz KA, Chen L, Kunin-Batson A, Chen Z, Woods WG, Gamis A, Kawashima T, Oeffinger KC, Nicholson HS, Neglia JP.

J Pediatr Hematol Oncol. 2017 Jan;39(1):20-25.

4.

Feasibility Study of a Novel Experimental Induction Protocol Combining B43-PAP (Anti-CD19) Immunotoxin With Standard Induction Chemotherapy in Children and Adolescents With Relapsed B-Lineage ALL: A Report From the Children's Oncology Group.

Meany HJ, Seibel NL, Krailo M, Villaluna D, Chen Z, Gaynon P, Neglia JP, Park JR, Hutchinson R, Sato JK, Wells RJ, Woods WG, Reaman G.

J Immunother. 2015 Sep;38(7):299-305. doi: 10.1097/CJI.0000000000000088.

5.

Robert J. Arceci, MD, PhD, 1950-2015.

Woods WG, Lange BJ.

Pediatr Blood Cancer. 2015 Aug;62(8):i-ii. doi: 10.1002/pbc.25657. Epub 2015 Jun 18. No abstract available.

PMID:
26089131
6.

The ASPHO 2014 distinguished career award goes to Dr. Beverly Lange.

Meadows AT, Woods WG, Maris JM.

Pediatr Blood Cancer. 2014 May;61 Suppl 1:A1-2. doi: 10.1002/pbc.25066. No abstract available.

PMID:
24842167
7.

Acute myeloid leukaemia (AML) with t(6;9)(p23;q34) is associated with poor outcome in childhood AML regardless of FLT3-ITD status: a report from the Children's Oncology Group.

Tarlock K, Alonzo TA, Moraleda PP, Gerbing RB, Raimondi SC, Hirsch BA, Ravindranath Y, Lange B, Woods WG, Gamis AS, Meshinchi S.

Br J Haematol. 2014 Jul;166(2):254-259. doi: 10.1111/bjh.12852. Epub 2014 Mar 25.

8.

Health conditions and quality of life in survivors of childhood acute myeloid leukemia comparing post remission chemotherapy to BMT: a report from the children's oncology group.

Schultz KA, Chen L, Chen Z, Kawashima T, Oeffinger KC, Woods WG, Nicholson HS, Neglia JP.

Pediatr Blood Cancer. 2014 Apr;61(4):729-36. doi: 10.1002/pbc.24881. Epub 2013 Nov 27.

9.

Outcome of adolescents and young adults with acute myeloid leukemia treated on COG trials compared to CALGB and SWOG trials.

Woods WG, Franklin AR, Alonzo TA, Gerbing RB, Donohue KA, Othus M, Horan J, Appelbaum FR, Estey EH, Bloomfield CD, Larson RA.

Cancer. 2013 Dec 1;119(23):4170-9. doi: 10.1002/cncr.28344. Epub 2013 Sep 19.

10.

Differences in outcomes of newly diagnosed acute myeloid leukemia for adolescent/young adult and younger patients: a report from the Children's Oncology Group.

Canner J, Alonzo TA, Franklin J, Freyer DR, Gamis A, Gerbing RB, Lange BJ, Meshinchi S, Woods WG, Perentesis J, Horan J.

Cancer. 2013 Dec 1;119(23):4162-9. doi: 10.1002/cncr.28342. Epub 2013 Sep 19.

11.

Outcome of pediatric patients with acute myeloid leukemia (AML) and -5/5q- abnormalities from five pediatric AML treatment protocols: a report from the Children's Oncology Group.

Johnston DL, Alonzo TA, Gerbing RB, Hirsch B, Heerema NA, Ravindranath Y, Woods WG, Lange BJ, Gamis AS, Raimondi SC.

Pediatr Blood Cancer. 2013 Dec;60(12):2073-8. doi: 10.1002/pbc.24573. Epub 2013 Aug 30.

PMID:
24039149
12.

Comparable survival for pediatric acute myeloid leukemia with poor-risk cytogenetics following chemotherapy, matched related donor, or unrelated donor transplantation.

Kelly MJ, Horan JT, Alonzo TA, Eapen M, Gerbing RB, He W, Lange BJ, Parsons SK, Woods WG.

Pediatr Blood Cancer. 2014 Feb;61(2):269-75. doi: 10.1002/pbc.24739. Epub 2013 Aug 19.

13.

Identification of regulators of polyploidization presents therapeutic targets for treatment of AMKL.

Wen Q, Goldenson B, Silver SJ, Schenone M, Dancik V, Huang Z, Wang LZ, Lewis TA, An WF, Li X, Bray MA, Thiollier C, Diebold L, Gilles L, Vokes MS, Moore CB, Bliss-Moreau M, Verplank L, Tolliday NJ, Mishra R, Vemula S, Shi J, Wei L, Kapur R, Lopez CK, Gerby B, Ballerini P, Pflumio F, Gilliland DG, Goldberg L, Birger Y, Izraeli S, Gamis AS, Smith FO, Woods WG, Taub J, Scherer CA, Bradner JE, Goh BC, Mercher T, Carpenter AE, Gould RJ, Clemons PA, Carr SA, Root DE, Schreiber SL, Stern AM, Crispino JD.

Cell. 2012 Aug 3;150(3):575-89. doi: 10.1016/j.cell.2012.06.032.

14.

Favorable survival maintained in children who have myeloid leukemia associated with Down syndrome using reduced-dose chemotherapy on Children's Oncology Group trial A2971: a report from the Children's Oncology Group.

Sorrell AD, Alonzo TA, Hilden JM, Gerbing RB, Loew TW, Hathaway L, Barnard D, Taub JW, Ravindranath Y, Smith FO, Arceci RJ, Woods WG, Gamis AS.

Cancer. 2012 Oct 1;118(19):4806-14. doi: 10.1002/cncr.27484. Epub 2012 Mar 5.

15.

FLT3 mutation status is a predictor of early death in pediatric acute promyelocytic leukemia: a report from the Children's Oncology Group.

Kutny MA, Moser BK, Laumann K, Feusner JH, Gamis A, Gregory J, Larson RA, Powell BL, Stock W, Willman CL, Woods WG, Meshinchi S.

Pediatr Blood Cancer. 2012 Oct;59(4):662-7. doi: 10.1002/pbc.24122. Epub 2012 Feb 29.

16.

Life-threatening and fatal infections in children with acute myeloid leukemia: a report from the Children's Oncology Group.

Sung L, Buxton A, Gamis A, Woods WG, Alonzo TA.

J Pediatr Hematol Oncol. 2012 Jan;34(1):e30-5. doi: 10.1097/MPH.0b013e31822817a6.

17.

Lessons from the past: opportunities to improve childhood cancer survivor care through outcomes investigations of historical therapeutic approaches for pediatric hematological malignancies.

Hudson MM, Neglia JP, Woods WG, Sandlund JT, Pui CH, Kun LE, Robison LL, Green DM.

Pediatr Blood Cancer. 2012 Mar;58(3):334-43. doi: 10.1002/pbc.23385. Epub 2011 Oct 28. Review.

18.

Superior outcome of pediatric acute myeloid leukemia patients with orbital and CNS myeloid sarcoma: a report from the Children's Oncology Group.

Johnston DL, Alonzo TA, Gerbing RB, Lange BJ, Woods WG.

Pediatr Blood Cancer. 2012 Apr;58(4):519-24. doi: 10.1002/pbc.23201. Epub 2011 May 25.

19.

Ya gotta have heart.

Lange BJ, Woods WG.

Pediatr Blood Cancer. 2011 Apr;56(4):513-4. doi: 10.1002/pbc.22997. Epub 2011 Jan 19. No abstract available.

PMID:
21298732
20.

Analysis of the role of hematopoietic stem-cell transplantation in infants with acute lymphoblastic leukemia in first remission and MLL gene rearrangements: a report from the Children's Oncology Group.

Dreyer ZE, Dinndorf PA, Camitta B, Sather H, La MK, Devidas M, Hilden JM, Heerema NA, Sanders JE, McGlennen R, Willman CL, Carroll AJ, Behm F, Smith FO, Woods WG, Godder K, Reaman GH.

J Clin Oncol. 2011 Jan 10;29(2):214-22. doi: 10.1200/JCO.2009.26.8938. Epub 2010 Dec 6.

21.

Unrelated donor bone marrow transplantation for myelodysplastic syndrome in children.

Woodard P, Carpenter PA, Davies SM, Gross TG, He W, Zhang MJ, Horn BN, Margolis DA, Perentesis JP, Sanders JE, Schultz KR, Seber A, Woods WG, Eapen M.

Biol Blood Marrow Transplant. 2011 May;17(5):723-8. doi: 10.1016/j.bbmt.2010.08.016. Epub 2010 Oct 8.

22.

Intracavitary cisplatin therapy for pediatric malignancies.

Katzenstein HM, Petricca S, Ricketts R, Wasilewski-Masker K, Powell C, Rapkin L, George B, Woods WG, Olson TA.

Pediatr Blood Cancer. 2010 Sep;55(3):452-6. doi: 10.1002/pbc.22508.

PMID:
20658616
23.

The presence of central nervous system disease at diagnosis in pediatric acute myeloid leukemia does not affect survival: a Children's Oncology Group study.

Johnston DL, Alonzo TA, Gerbing RB, Lange BJ, Woods WG.

Pediatr Blood Cancer. 2010 Sep;55(3):414-20. doi: 10.1002/pbc.22511.

24.

A meta-analysis comparing side to end with colonic J-pouch formation after anterior resection for rectal cancer.

Siddiqui MR, Sajid MS, Woods WG, Cheek E, Baig MK.

Tech Coloproctol. 2010 Jun;14(2):113-23. doi: 10.1007/s10151-010-0576-1. Epub 2010 Apr 27.

PMID:
20422436
25.

Prevalence and prognostic significance of KIT mutations in pediatric patients with core binding factor AML enrolled on serial pediatric cooperative trials for de novo AML.

Pollard JA, Alonzo TA, Gerbing RB, Ho PA, Zeng R, Ravindranath Y, Dahl G, Lacayo NJ, Becton D, Chang M, Weinstein HJ, Hirsch B, Raimondi SC, Heerema NA, Woods WG, Lange BJ, Hurwitz C, Arceci RJ, Radich JP, Bernstein ID, Heinrich MC, Meshinchi S.

Blood. 2010 Mar 25;115(12):2372-9. doi: 10.1182/blood-2009-09-241075. Epub 2010 Jan 7.

26.

An isolated lump in right groin: an unusual initial presentation of Crohn's disease.

Ray K, Tonsi AE, Woods WG, Baig MK.

Acta Chir Belg. 2009 Jan-Feb;109(1):98-100.

PMID:
19341206
27.

Infections and association with different intensity of chemotherapy in children with acute myeloid leukemia.

Sung L, Gamis A, Alonzo TA, Buxton A, Britton K, Deswarte-Wallace J, Woods WG.

Cancer. 2009 Mar 1;115(5):1100-8. doi: 10.1002/cncr.24107. Erratum in: Cancer. 2009 Jun 15;115(12):2807.

28.

A polymerase chain reaction-coupled high-resolution melting curve analytical approach for the monitoring of monospecificity of avian Eimeria species.

Kirkpatrick NC, Blacker HP, Woods WG, Gasser RB, Noormohammadi AH.

Avian Pathol. 2009 Feb;38(1):13-9. doi: 10.1080/03079450802596053.

PMID:
19156576
29.

The drama of the gifted disease.

Woods WG, LaQuaglia MP.

J Clin Oncol. 2009 Jan 10;27(2):172-3. doi: 10.1200/JCO.2008.19.2153. Epub 2008 Dec 1. No abstract available.

PMID:
19047304
30.

Sickle cell disease summit: from clinical and research disparity to action.

Hassell K, Pace B, Wang W, Kulkarni R, Luban N, Johnson CS, Eckman J, Lane P, Woods WG; American Society of Pediatric Hematology Oncology.

Am J Hematol. 2009 Jan;84(1):39-45. doi: 10.1002/ajh.21315.

31.

Impact of disease risk on efficacy of matched related bone marrow transplantation for pediatric acute myeloid leukemia: the Children's Oncology Group.

Horan JT, Alonzo TA, Lyman GH, Gerbing RB, Lange BJ, Ravindranath Y, Becton D, Smith FO, Woods WG; Children's Oncology Group.

J Clin Oncol. 2008 Dec 10;26(35):5797-801. doi: 10.1200/JCO.2007.13.5244. Epub 2008 Oct 27.

32.

Perforated caecal volvulus: an unusual complication after anterior resection for colorectal carcinoma.

Sajid MS, Iftikhar M, Rimpel J, Baig M, Woods WG.

Acta Chir Belg. 2008 Jul-Aug;108(4):460-1.

PMID:
18807604
33.

Respiratory syncytial virus infections in children with acute myeloid leukemia: a report from the Children's Oncology Group.

Sung L, Alonzo TA, Gerbing RB, Aplenc R, Lange BJ, Woods WG, Feusner J, Franklin J, Patterson MJ, Gamis AS; Children's Oncology Group.

Pediatr Blood Cancer. 2008 Dec;51(6):784-6. doi: 10.1002/pbc.21710.

34.

Screening for neuroblastoma: a resurrected idea?

Maris JM, Woods WG.

Lancet. 2008 Apr 5;371(9619):1142-3. doi: 10.1016/S0140-6736(08)60500-0. No abstract available.

PMID:
18395561
35.

Genetic characterization of three unique operational taxonomic units of Eimeria from chickens in Australia based on nuclear spacer ribosomal DNA.

Cantacessi C, Riddell S, Morris GM, Doran T, Woods WG, Otranto D, Gasser RB.

Vet Parasitol. 2008 Apr 15;152(3-4):226-34. doi: 10.1016/j.vetpar.2007.12.028. Epub 2007 Dec 27.

PMID:
18243560
36.

Incidence of neuroblastoma after a screening program.

Barrette S, Bernstein ML, Robison LL, Samson Y, Brossard J, Weitzman S, Woods WG.

J Clin Oncol. 2007 Nov 1;25(31):4929-32.

PMID:
17971590
37.
38.

Internet information on colorectal cancer: commercialization and lack of quality control.

Sajid MS, Iftikhar M, Monteiro RS, Miles AF, Woods WG, Baig MK.

Colorectal Dis. 2008 May;10(4):352-6. Epub 2007 Jul 20.

PMID:
17645570
39.

Autologous bone marrow transplantation for children with AML in first remission.

Neudorf S, Sanders J, Kobrinsky N, Alonzo TA, Buxton A, Buckley JD, Howells W, Gold S, Barnard DR, DeSwarte J, Kalousek D, Lange BJ, Woods WG.

Bone Marrow Transplant. 2007 Aug;40(4):313-8. Epub 2007 Jun 11.

PMID:
17563741
40.
41.

Investigating a persistent coccidiosis problem on a commercial broiler-breeder farm utilising PCR-coupled capillary electrophoresis.

Morris GM, Woods WG, Richards DG, Gasser RB.

Parasitol Res. 2007 Aug;101(3):583-9. Epub 2007 Apr 3.

PMID:
17404757
42.

Does rectus sheath infusion of bupivacaine reduce postoperative opioid requirement?

Padmanabhan J, Rohatgi A, Niaz A, Chojnowska E, Baig K, Woods WG.

Ann R Coll Surg Engl. 2007 Apr;89(3):229-32.

43.

Lessons to be learned: a case study approach. Lateral aberrant thyroid tissue: is it always malignant?

Escofet X, Khan AZ, Mazarani W, Woods WG.

J R Soc Promot Health. 2007 Jan;127(1):45-6.

PMID:
17319317
44.

Monosomy 7 and deletion 7q in children and adolescents with acute myeloid leukemia: an international retrospective study.

Hasle H, Alonzo TA, Auvrignon A, Behar C, Chang M, Creutzig U, Fischer A, Forestier E, Fynn A, Haas OA, Harbott J, Harrison CJ, Heerema NA, van den Heuvel-Eibrink MM, Kaspers GJ, Locatelli F, Noellke P, Polychronopoulou S, Ravindranath Y, Razzouk B, Reinhardt D, Savva NN, Stark B, Suciu S, Tsukimoto I, Webb DK, Wojcik D, Woods WG, Zimmermann M, Niemeyer CM, Raimondi SC.

Blood. 2007 Jun 1;109(11):4641-7. Epub 2007 Feb 13.

45.

Outcomes in childhood AML in the absence of transplantation in first remission--Children's Cancer Group (CCG) studies 2891 and CCG 213.

Castellino SM, Alonzo TA, Buxton A, Gold S, Lange BJ, Woods WG.

Pediatr Blood Cancer. 2008 Jan;50(1):9-16.

PMID:
17252564
46.

Minimally differentiated acute myeloid leukemia (FAB AML-M0) is associated with an adverse outcome in children: a report from the Children's Oncology Group, studies CCG-2891 and CCG-2961.

Barbaric D, Alonzo TA, Gerbing RB, Meshinchi S, Heerema NA, Barnard DR, Lange BJ, Woods WG, Arceci RJ, Smith FO.

Blood. 2007 Mar 15;109(6):2314-21. Epub 2006 Dec 7.

47.

Comparison of childhood myelodysplastic syndrome, AML FAB M6 or M7, CCG 2891: report from the Children's Oncology Group.

Barnard DR, Alonzo TA, Gerbing RB, Lange B, Woods WG; Children's Oncology Group.

Pediatr Blood Cancer. 2007 Jul;49(1):17-22.

PMID:
16856158
48.

FLT3 internal tandem duplication in CD34+/CD33- precursors predicts poor outcome in acute myeloid leukemia.

Pollard JA, Alonzo TA, Gerbing RB, Woods WG, Lange BJ, Sweetser DA, Radich JP, Bernstein ID, Meshinchi S.

Blood. 2006 Oct 15;108(8):2764-9. Epub 2006 Jun 29.

49.

Treatment complications in children diagnosed with neuroblastoma during a screening program.

Barrette S, Bernstein ML, Leclerc JM, Champagne MA, Samson Y, Brossard J, Woods WG.

J Clin Oncol. 2006 Apr 1;24(10):1542-5.

PMID:
16575005
50.

Analysis of prognostic factors of acute lymphoblastic leukemia in infants: report on CCG 1953 from the Children's Oncology Group.

Hilden JM, Dinndorf PA, Meerbaum SO, Sather H, Villaluna D, Heerema NA, McGlennen R, Smith FO, Woods WG, Salzer WL, Johnstone HS, Dreyer Z, Reaman GH; Children's Oncology Group.

Blood. 2006 Jul 15;108(2):441-51. Epub 2006 Mar 23.

Supplemental Content

Loading ...
Support Center